Brought to you by 
Proteus Digital Health brings in $62.5mm through its Series F venture round
21 Apr 2021
Executive Summary
Proteus Digital Health Inc. (formerly Proteus Biomedical) has raised $62.5mm through its Series F venture round. New backer Oracle Corp. joins Otsuka Pharmaceutical Co. Ltd., Novartis AG, Sino Portfolio, and additional unnamed investors. The company has developed a digital feedback system that includes wearable and ingestible sensors to ensure that patients comply with the administration of medicine, to measure physiologic response, and overall health management.
Deal Industry
- Pharmaceuticals
-
Medical Devices
- Monitoring Equipment & Devices
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Proteus Digital Health brings in $62.5mm through its Series F venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice